These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20189432)

  • 1. [In reference to the article: "Neck dissection following chemoradiation for node positive head and neck carcinomas" by Thariat et al. Cancer Radiother 2009;13:758-770].
    Maillard S; Merol JC; Chays A; Nguyen TD
    Cancer Radiother; 2010 Jun; 14(3):222; author reply 222-4. PubMed ID: 20189432
    [No Abstract]   [Full Text] [Related]  

  • 2. Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.
    Haddad R; Tishler RB; Norris CM; Mahadevan A; Busse P; Wirth L; Goguen LA; Sullivan CA; Costello R; Case MA; Posner MR
    Oncologist; 2003; 8(1):35-44. PubMed ID: 12604730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy prior to surgery in head and neck cancer.
    Paterson C; Robertson AG; Grose D; Correa PD; Rizwanullah M
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):79-80. PubMed ID: 22070911
    [No Abstract]   [Full Text] [Related]  

  • 4. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Four cases of hypopharyngeal cancer treated with docetaxel, cisplatin, and 5-FU followed by radiotherapy and/or neck dissection].
    Miyahara H; Nario K; Matsushiro N; Sasai H; Kajikawa H
    Gan To Kagaku Ryoho; 2004 May; 31(5):739-42. PubMed ID: 15170983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?
    Specenier PM; Vermorken JB
    Cancer Lett; 2007 Oct; 256(2):166-77. PubMed ID: 17673364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?
    McHam SA; Adelstein DJ; Rybicki LA; Lavertu P; Esclamado RM; Wood BG; Strome M; Carroll MA
    Head Neck; 2003 Oct; 25(10):791-8. PubMed ID: 12966502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
    Forastiere AA
    J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy in unresectable head and neck cancer.
    Bölke E; Peiper M; Gripp S
    N Engl J Med; 2008 Mar; 358(10):1075; author reply 1075. PubMed ID: 18322292
    [No Abstract]   [Full Text] [Related]  

  • 10. Early nodal response as a predictor for necessity of functional neck dissection after chemoradiation.
    Vongtama R; Lee M; Kim B; Sercarz J; Lin K; Suchard MA; Lee SP; Juillard G
    Cancer J; 2004; 10(6):339-42. PubMed ID: 15701264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future chemotherapy and radiotherapy options in head and neck cancer.
    Merlano M; Mattiot VP
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):395-403. PubMed ID: 16503856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impending Carotid Blowout Syndrome.
    Peguero J; Khanfar A; Mannem S; Willis M; Markowtiz A
    J Clin Oncol; 2015 Aug; 33(23):e97-8. PubMed ID: 24687819
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of head and neck cancer.
    Trotti A; Pajak TF; Ridge JA
    N Engl J Med; 2008 Mar; 358(10):1076; author reply 1077-8. PubMed ID: 18326079
    [No Abstract]   [Full Text] [Related]  

  • 14. Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy.
    Yovino S; Settle K; Taylor R; Wolf J; Kwok Y; Cullen K; Ord R; Zimrin A; Strome S; Suntharalingam M
    Head Neck; 2010 Jan; 32(1):46-52. PubMed ID: 19484762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should cetuximab replace cisplatin in head and neck cancer?
    Rowan K
    J Natl Cancer Inst; 2010 Jan; 102(2):74-6, 78. PubMed ID: 20054019
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer.
    Garden AS; Gunn GB; Hessel A; Beadle BM; Ahmed S; El-Naggar AK; Fuller CD; Byers LA; Phan J; Frank SJ; Morrison WH; Kies MS; Rosenthal DI; Sturgis EM
    Cancer; 2014 Oct; 120(19):3082-8. PubMed ID: 24898672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
    Kovács AF; Mose S; Böttcher HD; Bitter K
    Strahlenther Onkol; 2005 Jan; 181(1):26-34. PubMed ID: 15660190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
    Vermorken JB; Remenar E; van Herpen C; Gorlia T; Mesia R; Degardin M; Stewart JS; Jelic S; Betka J; Preiss JH; van den Weyngaert D; Awada A; Cupissol D; Kienzer HR; Rey A; Desaunois I; Bernier J; Lefebvre JL;
    N Engl J Med; 2007 Oct; 357(17):1695-704. PubMed ID: 17960012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of head and neck cancer.
    Nutting CM; Bhide SA; Harrington KJ
    N Engl J Med; 2008 Mar; 358(10):1076-7; author reply 1077-8. PubMed ID: 18326077
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of advanced nodal disease following chemoradiation for head and neck squamous cell carcinoma: role of magnetic resonance imaging.
    Lin D; Glastonbury CM; Rafaelian O; Eisele DW; Wang SJ
    J Otolaryngol; 2007 Dec; 36(6):350-6. PubMed ID: 18076845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.